Ensuring biological sample integrity from collection to analysis for LC–MS workflows: case studies illustrating challenges in clinical trials

In this special report, Melanie Anderson (Merck and Co., Inc.; PA, USA) presents several case studies and discusses the logistical challenges associated with unstable compounds and unique matrices for LC–MS/MS workflows. She also discusses how we can ensure sample integrity and how this is crucial for providing reliable data from clinical trials. This article is from the special focus issue published by Bioanalysis on Stability Issues in Bioanalysis. Keywords: analyte stability, dried blood spot, peripheral blood mononuclear cells, sample collection, sample integrity In quantitative bioanalysis, ensuring sample integrity through the life cycle of a sample is crucial for providing reliable data. Sponsors must develop proper...

To view this content, please register now for access

It's completely free